ClinicalTrials.gov
ClinicalTrials.gov Menu

A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis (CanTOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01142583
Recruitment Status : Completed
First Posted : June 11, 2010
Last Update Posted : March 18, 2014
Sponsor:
Information provided by (Responsible Party):
Merck KGaA

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2009
  Actual Study Completion Date : August 2009